KalshiVerfügbarkeit prüfenKYC erforderlich2% GebührVerifizierte AuflösungsdatenOrdentlich kalibriertWarnung zur DatenqualitätKeine Handelsaktivität
Daten vom 09.09.2026, 10:30 UTC · Richtlinie pm-quality-3
Aktuelle implizite Wahrscheinlichkeit
Above 4.2 million 0%Führend unter 5 Optionen
Marktqualitat
31 / 100
Niedrige Qualität24h-Volumen
—
Liquidität
—
Liquidität unbekanntSpread
7.0 pt
Breiter SpreadMarktdaten
Aktualisiert vor 10 Minuten
13. Aug. 26, 02:26 UTC27. Mai 27, 05:00 UTC
Trends
0%
0%
0%
0%
0%
Verwandte Märkte
Verwandte Fragen als Kontext, kein Vergleich gleichwertiger Kontrakte.
Natera tests processed in Q3
KalshiPaymentus transactions processed in fiscal 2026
KalshiPaymentus transactions processed in Q3
KalshiWill there be >250k tech layoffs in 2027 according to Layoffs.fyi?
Manifold MarketsWill Aurelia Song abandon Nectome before 2041?
Manifold MarketsWhich fast food chain in the USA will offer a lab-grown / cultivated meat product first?
Manifold MarketsRegeln
If Natera, Inc. reports Above 4200000 tests processed in fiscal 2026, then the market resolves to Yes.
Abwicklung über:Fiscal.ai
- This market refers to the annual figure reported in Natera, Inc.'s full fiscal year or Q4 earnings release.
- Kalshi is not affiliated, associated, authorized, endorsed by, or in any way officially connected with the underlying company.
- All trademarks, logos, and brand names are the property of their respective owners.
- If Natera, Inc. reports Above 4250000 tests processed in fiscal 2026, then the market resolves to Yes.
- If Natera, Inc. reports Above 4300000 tests processed in fiscal 2026, then the market resolves to Yes.
Offene Märkte
Health & Medicine
POLYMARKETHantavirus pandemic in 2026?
- No-0.2pt97%
- Yes+0.2pt3%
- Gesamtvolumen
- 15,6 Mio. €
- 24h-Volumen
- 20.274 €
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+0.6pt4%
- Gesamtvolumen
- 1,6 Mio. €
- 24h-Volumen
- 7973 €
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+4.0pt65%
- September41%
- June28%
- Gesamtvolumen
- 84.059,6 €
POLYMARKETEbola pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Gesamtvolumen
- 652.610,8 €
- 24h-Volumen
- 3393 €
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 6000-4.0pt58%
+2 weitere Ergebnisse
- Gesamtvolumen
- 865.434,4 €
- 24h-Volumen
- 2965,1 €
POLYMARKETNew pandemic in 2026?
- No+1.0pt94.1%
- Yes-1.0pt5.9%
- Gesamtvolumen
- 915.243,4 €
- 24h-Volumen
- 1248,8 €
- When will the FDA approve Intellia Therapeutics' lonvo-z?
- Will 3 mg THC beverages be federally legal to sell?
- Measles cases in U.S. in 2026?
- Cyclosporiasis cases reported in the US in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve CagriSema?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- FDA decision: Ifinatamab Deruxtecan by Daiichi Sankyo (in 2026)
- When will Compass Pathways submit a NDA for COMP360 psilocybin?
Häufige Fragen
- Wie stehen die aktuellen Quoten für Natera tests processed in fiscal 2026?
- Kalshi bewertet Above 4.2 million mit 0% (Stand: 9. September 2026).
- Wann wird Natera tests processed in fiscal 2026 entschieden?
- Natera tests processed in fiscal 2026 soll am 27. Mai 2027 entschieden werden.
- Wie wird Natera tests processed in fiscal 2026 abgerechnet?
- Kalshi rechnet diesen Markt wie folgt ab: If Natera, Inc. reports Above 4200000 tests processed in fiscal 2026, then the market resolves to Yes.